Archive

New INET research shows once again that it’s large firms and the 1%—not the “median voter”—who drive U.S. policy

“Third, U.S. taxpayers foot a huge portion of the bill for basic science leading to new drugs. The National Institutes of Health is the single largest source of biomedical research in the world. In fact, NIH funding contributed to research associated with every single new drug approved by the FDA from 2010-2019, totaling $230 billion according to a recent report.”

In this paper we analyze the Gilens dataset using the complementary tools of Random Forest classifiers (RFs), from Machine Learning.

In this interview, Dr. Vera Songwe, economist and Executive Secretary of the United Nations Economic Commission for Africa reflects on the ways that African governments have handled COVID-19, the role of the Continental Free Trade Agreement in turbo-charging future growth, the vital role of infrastructural investment and mobilising domestic resources for building forward better and greener.

“Executives have an interest in getting the stock price up and price gouging customers is one way they can do this,” said William Lazonick, professor emeritus of economics at University of Massachusetts and co-founder of the Academic-Industry Research Network. While many drug companies argue that they use their vast profits to fund ongoing pharmaceutical innovation, Lazonick said, “we’ve shown that most of these companies don’t do that.” Instead, the soaring prices fuel soaring stock prices and executive pay, which is often based largely on that price.” — INET Grantee William Lazonick

“Alberto Baccini, an economist at the University of Siena in Italy, says that people assessing research should be aware that the process can have an influence on academics’ behavior. ‘For each research assessment, you can find some behavior that changes in a way that is not desirable for society,’ he says. A 2019 study conducted by Baccini and colleagues found that researchers in Italy have been citing their own work or that authored by other researchers based at Italian institutions more frequently in response to a 2010 policy that is used to make decisions on promotions based on the number of citations researchers accumulate.” — INET Grantee Alberto Baccini

“Obviously, there’s serious work to be done in changing cultural norms. Dealing with this disrespectful activity requires a versatile toolkit. … Fortunately, cultural norms can change. Challenges to traditional patriarchy and outdated workplace behavior, like the #MeToo movement, are already shifting notions of what is acceptable. Lesley Stahl has been a respected journalist for 50 years. Which means she likely knows better than anyone else that gaining a seat at the table doesn’t mean much if you can’t be heard over the din.” — INET Senior Research Analyst Lynn Parramore

“In his speech, Xi pledged to uphold support for the Greater Bay Area initiative, and the Shenzhen plan includes specific measures to create employment and housing opportunities for Hong Kong’s young people. Driving forward the development of an economy as large and complex as China’s is a monumental feat in the best of times – not least because there are no models to emulate. Amid hostile external conditions, the challenge is even greater. But with the Shenzhen plan – and the broader adaptation and implementation of the city’s successful reforms – China may well be able to meet it.” - INET Expert Andrew Sheng, member of Commission on Global Economic Transformation

George Soros explains why there is no mathematical equation that can define humanity.

Unregistered lobbyists, including former members of Congress, are a key resource for lobbying firms

Unregistered lobbyists, including former members of Congress, are a key resource for lobbying firms

In the future, how will work be different, what jobs are most at risk, what jobs are likely to grow?

David Mussington, a leading expert on cybersecurity, reveals what’s worrying him, from Facebook to foreign interference.

Dr. Ming Lin spoke out about Covid safety at his hospital and was fired. He’s fighting back against a system that put profits over human life.

What is the current situation in credit markets? Will an overhang of debt on corporate balance sheets slow down the recovery from the COVID recession and be a drag on investment going forward? Does the COVID recession still have the potential to turn into a broader financial meltdown?